Additionally, a meta-analysis of randomized controlled trials (RCTs)assessing the safety and efficacy of GLP-1 and Gcg RAs, including cotadutide,found that these agents significantly reduced body weight and improved glycemiccontrol in individuals with T2D and obesity. The gene discussed is GCG; the disease is type 2 diabetes mellitus.